Yde Ohki CM, McNeill RV, Nieberler M, Radtke F, Kittel-Schneider S, Grünblatt E (2022)
Publication Type: Book chapter / Article in edited volumes
Publication year: 2022
Publisher: Springer Science and Business Media Deutschland GmbH
Series: Current Topics in Behavioral Neurosciences
Book Volume: 57
Pages Range: 483-501
Although research using animal models, peripheral and clinical biomarkers, multimodal neuroimaging techniques and (epi)genetic information has advanced our understanding of Attention-Deficit Hyperactivity Disorder (ADHD), the aetiopathology of this neurodevelopmental disorder has still not been elucidated. Moreover, as the primary affected tissue is the brain, access to samples is problematic. Alternative models are therefore required, facilitating cellular and molecular analysis. Recent developments in stem cell research have introduced the possibility to reprogram somatic cells from patients, in this case ADHD, and healthy controls back into their pluripotent state, meaning that they can then be differentiated into any cell or tissue type. The potential to translate patients’ somatic cells into stem cells, and thereafter to use 2- and 3-dimensional (2D and 3D) neuronal cells to model neurodevelopmental disorders and/or test novel drug therapeutics, is discussed in this chapter.
APA:
Yde Ohki, C.M., McNeill, R.V., Nieberler, M., Radtke, F., Kittel-Schneider, S., & Grünblatt, E. (2022). Promising Developments in the Use of Induced Pluripotent Stem Cells in Research of ADHD. In (pp. 483-501). Springer Science and Business Media Deutschland GmbH.
MLA:
Yde Ohki, Cristine Marie, et al. "Promising Developments in the Use of Induced Pluripotent Stem Cells in Research of ADHD." Springer Science and Business Media Deutschland GmbH, 2022. 483-501.
BibTeX: Download